1. Home
  2. SSKN vs TOVX Comparison

SSKN vs TOVX Comparison

Compare SSKN & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Strata Skin Sciences Inc.

SSKN

Strata Skin Sciences Inc.

HOLD

Current Price

$1.35

Market Cap

8.9M

Sector

Health Care

ML Signal

HOLD

TOVX

Theriva Biologics Inc.

HOLD

Current Price

$0.22

Market Cap

7.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSKN
TOVX
Founded
1989
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9M
7.3M
IPO Year
2005
2006

Fundamental Metrics

Financial Performance
Metric
SSKN
TOVX
Price
$1.35
$0.22
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$6.00
N/A
AVG Volume (30 Days)
126.1K
10.7M
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$30,980,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.18
$0.17
52 Week High
$3.86
$2.03

Technical Indicators

Market Signals
Indicator
SSKN
TOVX
Relative Strength Index (RSI) 48.83 48.84
Support Level $1.18 $0.19
Resistance Level $1.39 $0.26
Average True Range (ATR) 0.10 0.03
MACD 0.02 0.01
Stochastic Oscillator 57.41 56.55

Price Performance

Historical Comparison
SSKN
TOVX

About SSKN Strata Skin Sciences Inc.

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Share on Social Networks: